Statistics

Total Visits

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor55

Select a period of time:

Number of views in the range

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor18

Views

Views
June 20250
July 202511
August 20251
September 20253
October 20250
November 20251
December 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
United Kingdom4
Brazil2
Argentina1
Bolivia1
Hong Kong1
Mexico1
Turkey1
 

Top cities views

Views
Ashburn1
Bluffton1
Hong Kong1
Hope1
Izmir1
Nova Resende1
Philadelphia1
Poza Rica1
Ronkonkoma1
San Juan Bautista1